The drugs are seen as being very exciting on the one hand, but just so long as there is no distraction from the other one, I think that that is something a concern that some people have voiced. Boots say they are confident that there are these procedures in place to make sure that these drugs do reach to people who need them and not those people who may be accessing them for the wrong reason.
Ian Sample speaks to Guardian science correspondent Nicola Davis about the news that Wegovy, an appetite suppressant popular with celebrities in the US, will soon be sold at UK pharmacies. It’s a prescription drug aimed at helping people with obesity lose weight, but some argue it doesn’t tackle the root cause of the disease. Help support our independent journalism at
theguardian.com/sciencepod